Structural formula: Panobinostat DL-lactate

FARYDAK 15 mg, hard capsule 6 capsules

Telegram WhatsApp

Link to share

Active ingredients: Panobinostat DL-lactate, Panobinostat

Commercialized according to BDPMDispensing in France: Prescription only

Hard capsule6 capsulesorale

No current ANSM shortage notice is included

Package details

Original BDPM fields are shown in French.

Official name: FARYDAK 15 mg, gélule
Pharmaceutical form: gélule
Route of administration: orale
Presentation description: 1 plaquette(s) PVC polychlortrifluoroéthylène aluminium de 6 gélule(s)
Marketing authorisation holder: PHARMAAND (AUTRICHE)
Reimbursement according to BDPM: —
Approval for use in healthcare institutions: non
Commercialization declaration date: 16 Nov 2015
Prescription and dispensing conditions: Prescription only
List I: prescription-only medicine
Requires special monitoring during treatment
Prescribed by a hospital doctor
Prescribed by specialists only
Original BDPM wording: liste I · médicament nécessitant une surveillance particulière pendant le traitement · prescription hospitalière · prescription réservée aux médecins compétents en CANCEROLOGIE · prescription réservée aux médecins compétents en maladie du sang · prescription réservée aux spécialistes et services HEMATOLOGIE · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE
Enhanced ANSM monitoring: No

BDPM identifiers

CIS60937038CIP73002468CIP133400930024683

Composition in BDPM

Composition in BDPM
Component	Amount per unit	Source type
LACTATE DE PANOBINOSTAT ANHYDREgélule	18,864 mg · une gélule	SA
PANOBINOSTATgélule	15 mg · une gélule	FT

Information is based on BDPM data and is for reference only. Consult a doctor before use.

Similar medicines

Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.

The current BDPM data does not list similar medicines for this product.